Dr. Michael A. Apostolis, MD

Dr. Apostolis practices at Lung & Wellness Centers of Western Pennsylvania in Butler, Pennsylvania.

Dr. Apostolis' NPI, 1770892713, was assigned on September 24, 2010. Dr. Apostolis holds Ohio license 35-099705.

Dr. Apostolis' primary practice is Lung & Wellness Centers of Western Pennsylvania, at 200 Renaissance Drive Suite 103, Butler, PA 16001. The practice phone is (724) 256-9606.

Dr. Apostolis' primary practice is Lung & Wellness Centers of Western Pennsylvania in Butler, Pennsylvania. Dr. Apostolis is also affiliated with Butler Memorial Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Apostolis to 2 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Apostolis practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Apostolis' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Apostolis is licensed in Ohio.

CMS data shows 666 Medicare services from Dr. Apostolis across 14 procedure codes in 2024, for 314 Medicare patients. Medicare paid $42,274 for them.

CMS counts 314 Medicare patients who saw Dr. Apostolis in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Apostolis' median patient age at 72, with 43% women.

In 2024, Dr. Apostolis wrote 1,171 Medicare Part D claims for 201 patients. 49% of them were for generic drugs. CMS names the drug for 1,046 of them, across 18 drugs with 11 or more claims each, at $382,640 in total drug cost. In 2023, CMS named 974 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Apostolis for performance year 2024, reported through an alternative payment model (APM). Dr. Apostolis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Apostolis in 2022. Dr. Apostolis' most frequent co-authors are Ahmed R. Abdelkarim, MD, Abdulmohsin M. Ahmadjee, MD and Ragheb A. Assaly, MD.

CMS Open Payments shows 485 general payments to Dr. Apostolis from 41 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. AstraZeneca Pharmaceuticals LP paid the most, $55,352.